NCDC Confirms Two Suspected Ebola Cases Adamawa Test Negative

In a reassuring update, the Nigeria Centre for Disease Control (NCDC) has announced that the two suspected Ebola cases Adamawa have tested negative after two rounds of laboratory analysis. The confirmation comes amid heightened vigilance following the first laboratory‑confirmed Bundibugyo Ebola case recorded earlier this year in the Federal Capital Territory (FCT). While the negative results bring temporary relief to residents of Adamawa, health officials stress that continued surveillance and rapid response remain essential to prevent any future outbreak.

Background: How Ebola Re‑emerged in Nigeria

Earlier in 2026, Nigeria recorded its first confirmed case of the Bundibugyo strain of Ebola Virus Disease (EVD) in the FCT, a development that triggered nationwide alerts and a surge in public‑health preparedness. The case, confirmed through PCR testing, was swiftly isolated, and contact tracing teams were deployed across the capital and neighbouring states. Since then, the NCDC has intensified training for frontline health workers, upgraded diagnostic capacity in regional labs, and launched community awareness campaigns to demystify Ebola transmission.

Adamawa State, located in the North‑East, shares porous borders with Cameroon and has historically been a corridor for cross‑border movement of people and goods. The state’s health infrastructure, though improving, still faces challenges such as limited cold‑chain facilities and occasional shortages of personal protective equipment (PPE). These factors made the two suspected cases a cause for concern among both officials and the public.

What Happened with the Ebola cases Adamawa?

On 28 October 2026, two patients from separate health facilities in Yola reported symptoms that overlapped with Ebola – high fever, severe headache, and unexplained bleeding. Both were immediately isolated and their samples sent to the Federal Reference Laboratory in Abuja for testing. The NCDC’s spokesperson, Dr Adaeze Okonkwo, explained that the protocol required two independent PCR tests, spaced 48 hours apart, to rule out false‑negative results.

After the first round of testing returned negative, the laboratory repeated the analysis using a different assay kit to ensure accuracy. The second round also confirmed the absence of Ebola viral RNA. Consequently, the NCDC announced on 1 November 2026 that the two suspected Ebola cases Adamawa were not infected, and the patients were discharged after a brief observation period.

Why the Double‑Testing Protocol Matters

Testing for Ebola demands a high degree of precision because false‑negative results could lead to unchecked spread, while false‑positives could cause unnecessary panic and strain resources. The NCDC’s decision to employ two separate PCR platforms aligns with World Health Organization (WHO) guidelines, which recommend confirmatory testing when dealing with high‑consequence pathogens.

• First test: Utilised a real‑time PCR kit approved by the African CDC, targeting the glycoprotein gene of the Bundibugyo strain.
• Second test: Employed a multiplex assay that simultaneously screens for Ebola, Marburg, and Lassa viruses, providing a broader safety net.

Both assays returned negative, giving health officials confidence in the result. The rigorous approach also reassures the public that the NCDC is not cutting corners, even when the stakes appear low.

Impact on Public Perception and Community Response

News of suspected Ebola cases can spread quickly on social media, especially in regions where misinformation is rampant. In Adamawa, local radio stations and community leaders played a pivotal role in disseminating accurate information. By collaborating with traditional rulers and youth groups, the state health ministry ensured that messages about the testing process and the negative outcome reached villages and urban centres alike.

Moreover, the NCDC leveraged its “Ebola Watch” mobile app, which sends real‑time alerts to registered users. The app’s notification on 1 November 2026 highlighted the negative test results and reminded citizens to report any unusual symptoms to the nearest health facility.

Lessons Learned for Future Outbreak Preparedness

The episode underscores several key lessons for Nigeria and the broader African region:

1. Rapid isolation and testing: Immediate containment of suspected cases limits the window for potential transmission.
2. Robust laboratory network: Having multiple accredited labs across the country reduces turnaround time and avoids bottlenecks.
3. Community engagement: Transparent communication builds trust and curtails rumors.
4. Cross‑border coordination: Adamawa’s proximity to Cameroon calls for joint surveillance mechanisms with neighbouring countries.

These insights are already feeding into the NCDC’s 2027 strategic plan, which aims to expand point‑of‑care testing kits to all 36 states and strengthen regional data‑sharing platforms.

What Nigerians Should Do Now

Even though the two suspected Ebola cases Adamawa tested negative, the lone confirmed case in the FCT remains a reminder that vigilance is non‑negotiable. Health experts recommend the following practical steps:

• Maintain good personal hygiene – wash hands with soap and water frequently.
• Avoid direct contact with bodily fluids of anyone who appears ill.
• Seek medical attention promptly if you develop fever, vomiting, or unexplained bleeding.
• Stay updated via official channels such as the NCDC website, the “Ebola Watch” app, and verified radio broadcasts.

By adhering to these measures, Nigerians can help keep the country Ebola‑free while supporting the health system’s early‑warning capabilities.

FAQ

1. How many confirmed Ebola cases are there in Nigeria as of November 2026?

Only one laboratory‑confirmed case – the Bundibugyo strain recorded in the Federal Capital Territory – remains active. All other suspected cases, including the two in Adamawa, have tested negative.

2. What symptoms should prompt me to seek testing?

Key symptoms include sudden high fever, severe headache, muscle pain, vomiting, diarrhoea, and any unexplained bleeding. If you experience any of these, especially after contact with a sick person, visit the nearest health centre immediately.

3. Is the “Ebola Watch” app safe to use?

Yes. The app is developed by the NCDC in partnership with the African CDC and follows strict data‑privacy standards. It provides real‑time alerts, symptom checkers, and guidance on where to get tested.

For the full official statement, see the NCDC release: NCDC: Two suspected Ebola cases in Adamawa test negative.

Related Reading

• Toluwanisings Tragedy Exposes Nigeria’s Poor Response to Health Emergencies
• Kwara Ministries Launch Ebola Awareness Campaign to Safeguard Residents
• Abia State Launches New Ebola Isolation Centre to Guard Against Outbreaks